ReviewPharmacology & therapeutics2019

Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies.

Junko Murai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.